FIELD: medicine.
SUBSTANCE: 30-60 minutes after the following fraction of radical irradiation on the 1st, 3rd and 5th day of each week for the whole period of irradiation, the preparation Molixan® 60 mg (2 ml) is introduced intramuscularly to the patient.
EFFECT: higher efficacy and safety of the chemotherapy ensured by relieving the manifestations of oral mucositis.
4 tbl, 2 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2009 | 
 | RU2401139C1 | 
| METHOD FOR TREATMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2007 | 
 | RU2347591C1 | 
| METHOD FOR OROPHARYNGEAL CANCER CHEMORADIATION | 2016 | 
 | RU2632542C1 | 
| METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX IN COMBINATION WITH RADIATION AND DRUG EXPOSURE | 2019 | 
 | RU2705109C2 | 
| METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 | 
 | RU2689875C2 | 
| METHOD OF CHEMORADIATION THERAPY OF LOW-LOCATED TUMOURS OF RECTUM AND ANAL CANAL | 2009 | 
 | RU2400268C1 | 
| METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 | 
 | RU2751818C2 | 
| METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 | 
 | RU2289364C1 | 
| METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 | 
 | RU2429032C1 | 
| METHOD FOR ASSESSING CURRENT STATE IN PATIENTS SUFFERING DISSEMINATED MALIGNANT SOLID NEW GROWTHS | 2012 | 
 | RU2504778C1 | 
Authors
Dates
2014-06-10—Published
2012-11-21—Filed